Premium
F3‐03‐02: EFFECTS OF A COMPREHENSIVE, INDIVIDUALIZED, PERSON‐CENTERED MANAGEMENT (CI‐PCM) PROGRAM ON ANXIOLYTIC MEDICATION USAGE IN PERSONS WITH MODERATE‐TO‐SEVERE ALZHEIMER'S DISEASE
Author(s) -
Reisberg Barry,
Shao Yongzhao,
Alshalabi Munther,
Hassan Mudasar,
Kenowsky Sunnie
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.2749
Subject(s) - alprazolam , clonazepam , anxiolytic , medicine , randomization , randomized controlled trial , physical therapy , anesthesia , psychiatry , anxiety